We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 5 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 2 actions collected · 2 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
SPCX is currently $160.95, and the consensus target price from 5 analysts is $164, indicating a slight upside potential from the current price. The highest target price is $227 and the lowest is $63, showing a wide range of opinions. While the overall consensus rating is 'Buy', CFRA recently initiated coverage with a 'Sell' rating.
Divergence: Overall analyst consensus supports 'Buy,' but CFRA presents a contrasting view with a 'Sell' rating.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 06. 13. | CFRA | — | Initiate coverage | — → Sell | — | CFRA: Sell |
| 2026. 06. 11. | KGI Securities | — | Initiate coverage | — → Outperform | — | KGI Securities: Outperform |